Dr. Srigadha Vivek Kumar
Consultant Medical Oncologist
Book appointment
We are here for you
Book appointment
| Specialty | Consultant Medical Oncologist |
| Work Days |
Dr. Srigadha Vivek Kumar
Consultant Medical Oncologist
- +91 9121515108, +91 9032363666
- hyderabadprimeclinics@gmail.com
Dr. Srigadha Vivek Kumar is a highly qualified Consultant Medical Oncologist with extensive experience in the diagnosis and treatment of various cancers. With a strong academic background and expertise in precision medicine and targeted therapy, he is committed to providing comprehensive and personalized cancer care. He is a respected oncologist in LB Nagar, dedicated to offering advanced treatment options tailored to each patient’s needs.
His expertise extends to targeted therapy, precision medicine, and clinical trials, ensuring that patients receive the most advanced and effective treatment options. With a patient-centric approach, he is dedicated to improving outcomes and enhancing the quality of life for individuals battling cancer.
Qualifications
| MBBS | Osmania Medical College, Hyderabad (2011-2017) |
|---|---|
| M.D (Internal Medicine) | Nizams Institute of Medical Sciences (NIMS), Hyderabad (2018-2021) |
| D.M (Medical Oncology) | Tata Memorial Hospital, Mumbai (2022-2025) |
Experience
4+ Years of Experience in the field of Medical Oncology
| S.No. | Expertise |
|---|---|
| 1 | Head and Neck Cancer |
| 2 | Lung Cancer |
| 3 | Breast Cancer |
| 4 | Urological and Gynecological Cancers |
| 5 | Hematological Malignancies |
Medical Career
Senior resident, Internal medicine
Nizams institute of medical sciences ,Hyderabad 2021-2022
Senior resident, Medical oncology
Tata memorial hospital,Mumbai 2025-2026.
Assistant professor(Ad-hoc) medical oncology
Tata memorial hospital,Mumbai 2025-2026.
Consultant, Medical oncology
Homi Bhabha Cancer Hospital & Research Centre- Visakhapatnam.2026
Clinical & Medical Interests
- Solid tumors with emphasis on thoracic oncology, breast cancer, and GI malignancies
- Haematolymphoid malignancies and Bone marrow Transplant
- Systemic therapy: chemotherapy, targeted therapy, immunotherapy
- Clinical research and real-world evidence studies
Professional Memberships
- Indian Society of Medical & Paediatric Oncology (ISMPO)
- European Society for Medical Oncology (ESMO)
Certifications
- Harvard Medical School Executive Education Certificate – Advanced management of oncological Diseases 2026
Publications
- Srigadha Vivek K.; Prabhash, Kumar; Noronha, Vanita; Joshi, Amit; Patil, Vijay M.; Menon, Nandini; Singh, Ajay K.; Shah, Minit. Cabozantinib: A narrative drug review. Cancer Research, Statistics, and Treatment 6(1):p 74-87, Jan–Mar 2023. | DOI: 10.4103/crst.crst_9_23
- Kumar Srigadha & Noronha, Vanita & Prabhash, Kumar. (2023). Authors’ reply to Bhattacharya. Cancer Research, Statistics, and Treatment. 6. 344-345. 10.4103/crst.crst_184_23.
- Noronha V, Sahu H, Kapoor A, Patil V, Menon N, Shah M, Davis D, Roy R, Vivek S, Janu A, Kaushal R, Prabhash K. Reduced frequency dosing of osimertinib in EGFR-mutant non-small cell lung carcinoma: real world data. Ecancermedicalscience. 2024 Jun 28;18:1721. doi: 10.3332/ecancer.2024.1721. PMID: 39021550; PMCID: PMC11254406.
- Noronha V, Patil VM, Menon N, Joshi A, Shah MJ, Singh A, Goud S, Shah S, More S, Nawale K, Nakti D, Yadav A, Jogdhankar S, Kaushal RK, Tiwari VK, Niyogi D, Purandare N, Janu A, Chakrabarty N, Mahajan A, Tibdewal A, Agarwal J, Pawar A, Chowdhury OR, Sharma V, Kapu V, Trikha M, Kumar SV, Kolkur M, Bhagyavant P, Peelay Z, Khedkar R, Jain M, Badwe RA, Prabhash K. Phase III randomized trial comparing neoadjuvant paclitaxel plus platinum with 5-fluorouracil plus platinum in esophageal or gastroesophageal junction squamous cell carcinoma. J Natl Cancer Inst. 2025 Jan 1;117(1):58-75. doi: 10.1093/jnci/djae214. PMID: 39222012.
- Srigadha Vivek Kumar,Seema Gulia,Prabhat Bhargava,Sushmita Rath, Tanuja Shet,Nita Nair,Sangeeta Desai,Asawari Patil, Shalaka Joshi,Palak Popat, Sudeep Gupta Retrospective and prospective analysis of microinvasive breast cancer: clinicopathological features, treatment and outcome.
- Anokhi Shah, S.S. Addagalla, S. Rath, V. Srigadha, B. Rekhi, N. Khanna, M. Ramadwar, M. Goel, S. Laskar, S. Ghosh, A. Janu, J.J. Manjali, S. Yadav, S. Patkar, P. Panjwani, P. Nayak, M. Pruthi, P. Hegde, P. Bhargava Systemic Therapy Effectiveness in Metastatic Non-Uterine Leiomyosarcoma :A Decade of Real-World Outcomes from an Indian Cohort.